SCHEMBL15924280

SCHEMBL15924280

CNC(=O)c1cn2ccccc2n1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.72
CYP1A2 P05177 2/20 0.72
CYP3A4 P08684 2/20 0.72
PTGS1 P23219 1/20 0.71
PTGS2 P35354 1/20 0.71
RAB9A P51151 8/20 0.68
NPC1 O15118 7/20 0.68
KDM4E B2RXH2 6/20 0.60
SMN1; SMN2 Q16637 3/20 0.60
ALDH1A1 P00352 3/20 0.60
PKM P14618 2/20 0.60
POLB P06746 1/20 0.60
TP53 P04637 2/20 0.52
HPGD P15428 2/20 0.50
ROCK1 Q13464 1/20 0.49
DRD2 P14416 1/20 0.48
DRD3 P35462 1/20 0.48
METTL3 Q86U44 1/20 0.48
CYP2C19 P33261 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4620787 0.84 MAPT (1.00) MAPTCYP1A2CYP3A4PTGS1PTGS2
SCHEMBL118449 0.83 PTGS1 (1.00) MAPTCYP1A2CYP3A4PTGS1PTGS2
SCHEMBL2334973 0.81 PTGS1 (0.96) MAPTCYP1A2CYP3A4PTGS1PTGS2
Hydrochloric Acid SCHEMBL8878519 0.81 PTGS1 (0.96) MAPTCYP1A2CYP3A4PTGS1PTGS2
Water SCHEMBL21708935 0.81 PTGS1 (0.96) MAPTCYP1A2CYP3A4PTGS1PTGS2
SCHEMBL7929884 0.81 PTGS1 (0.72) MAPTCYP1A2CYP3A4PTGS1PTGS2
Bromide SCHEMBL570786 0.81 PTGS1 (0.96) MAPTCYP1A2CYP3A4PTGS1PTGS2
SCHEMBL2468923 0.81 RAB9A (1.00) MAPTCYP1A2CYP3A4PTGS1PTGS2
SCHEMBL31040086 0.81 MAPT (0.68) MAPTCYP1A2CYP3A4PTGS1PTGS2
SCHEMBL1583201 0.81 PTGS1 (0.66) MAPTCYP1A2CYP3A4PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115551864-A Substituted tricyclic amides, analogs thereof, and methods of using the same 爱彼特生物制药公司 2022-12-30 CN disclosed
WO-2017075694-A1 ANTIBIOTIC COMPOUNDS, PHARMACEUTICAL FORMULATIONS THEREOF AND METHODS AND USES THEREFOR SIMON FRASER UNIVERSITY (CA) 2017-05-11 WO disclosed
WO-2015017407-A1 BRIDGED BICYCLIC AMINO THIAZINE DIOXIDE COMPOUNDS AS INHIBITORS OF BETA- SECRETASE AMGEN INC. (US) 2015-02-05 WO disclosed
WO-2014120658-A1 FUSED MULTICYCLIC 3-AMINO-5,6-DIHYDRO-2H-1,4-THIAZINE DERIVATIVES AND THEIR USE AS BETA-SECRETASE INHIBITORS AMGEN INC. (US) 2014-08-07 WO disclosed
WO-2014059185-A1 AMINO - DIHYDROTHIAZINE AND AMINO - DIOXIDO DIHYDROTHIAZINE COMPOUNDS AS BETA-SECRETASE ANTAGONISTS AND METHODS OF USE AMGEN INC. (US) 2014-04-17 WO disclosed